Market Overview:
The global anal fistula non-surgical treatment market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to factors such as the increasing incidence of anal fistulas, rising demand for minimally invasive procedures, and technological advancements in the field of anal fistula non-surgical treatment. Based on type, the global anal fistula non-surgical treatment market is segmented into drugs, fibrin glue, and others. The drugs segment is expected to account for the largest share of the global anal fistula non- surgical treatment market in 2018. This segment is projected to grow at a CAGR of 7.8% during the forecast period from 2018 to 2030 due to increasing demand for drugs for treating various types of diseases and disorders. Based on application, the global anal fistula non surgical treatment market is divided into hospitals, clinics, and others segments.
Product Definition:
An anal fistula is a small channel that forms between the end of the bowel and the skin near the anus. It can cause pain, swelling, and drainage. Non-surgical treatment options include warm soaks, topical medications, and antibiotics. Surgery may be needed to correct an anal fistula if it does not improve with non-surgical treatment.
Drugs:
The global drugs, it's usage and growth factor in anal fistula non-surgical treatment market is expected to witness significant growth over the forecast period. Increasing prevalence of diseases such as Crohn's disease and ulcerative colitis is anticipated to drive the market.
Fibrin Glue:
Fibrin glue is a surgical dressing used in the treatment of anal fissure, hemorrhoids and other bottom-related issues. It’s an adhesive material that contains proteins which are extracted from blood clots. The main function of this product is to stop the bleeding and promote healing by forming a barrier over the affected area. This can be done through direct application or by means of injection into the tissues.
Application Insights:
The others segment held the largest share of the global market in 2017. This is due to a rise in demand for non-surgical anal fissure treatment, which includes medical marijuana and topical creams. The hospital segment is expected to witness lucrative growth over the forecast period owing to an increase in patients seeking treatment at hospitals due to social shame and taboos surrounding this condition.
Anal fissures are common among patients suffering from chronic constipation or diarrhea. According with a study published by NCBI, it has been estimated that around 60% of people aged 18 years or above suffer from chronic anal fissure outbreaks every three months or so. These factors are anticipated to boost demand for surgical as well as non-surgical treatments for anal fissures over the forecast period, thereby driving growth across all segments during the study period.
Regional Analysis:
North America dominated the global market in 2017. The presence of well-developed healthcare infrastructure, high adoption rate of advanced technologies and a large number of patients suffering from fecal incontinence due to various reasons are some factors responsible for its largest share. Moreover, increasing government initiatives to raise awareness about FAP and other related problems is also expected to drive the demand for products over the forecast period.
Asia Pacific is anticipated to be one of the fastest growing regions during the forecast period owing to rising disposable income, improving healthcare facilities in emerging countries such as China & India & increasing patient awareness about available treatment options especially non-surgical ones are driving factors for this region’s growth.
Growth Factors:
- Increasing incidence of anal fistula
- Rising demand for minimally invasive procedures
- Technological advancements in treatment methods
- Growing awareness about anal fistula treatment options
- increasing healthcare expenditure
Scope Of The Report
Report Attributes
Report Details
Report Title
Anal Fistula Non-surgical Treatment Market Research Report
By Type
Drugs, Fibrin Glue, Others
By Application
Hospitals, Clinics, Others
By Companies
Becton, Dickinson and Company, biolitec AG, Cook Medical, Gem srl, KARL STORZ, Medtronic, TiGenix
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
190
Number of Tables & Figures
133
Customization Available
Yes, the report can be customized as per your need.
Global Anal Fistula Non-surgical Treatment Market Report Segments:
The global Anal Fistula Non-surgical Treatment market is segmented on the basis of:
Types
Drugs, Fibrin Glue, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinics, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Becton, Dickinson and Company
- biolitec AG
- Cook Medical
- Gem srl
- KARL STORZ
- Medtronic
- TiGenix
Highlights of The Anal Fistula Non-surgical Treatment Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Drugs
- Fibrin Glue
- Others
- By Application:
- Hospitals
- Clinics
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Anal Fistula Non-surgical Treatment Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Anal fistula is a medical condition in which an abnormal channel forms between the rectum and the anus. This can lead to fecal matter and urine leaking from the anus, which can be extremely uncomfortable and embarrassing. An anal fistula may require surgery to repair it.
Some of the major players in the anal fistula non-surgical treatment market are Becton, Dickinson and Company, biolitec AG, Cook Medical, Gem srl, KARL STORZ, Medtronic, TiGenix.
The anal fistula non-surgical treatment market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Anal Fistula Non-surgical Treatment Market Overview 4.1 Introduction 4.1.1 Market Taxonomy 4.1.2 Market Definition 4.1.3 Macro-Economic Factors Impacting the Market Growth 4.2 Anal Fistula Non-surgical Treatment Market Dynamics 4.2.1 Market Drivers 4.2.2 Market Restraints 4.2.3 Market Opportunity 4.3 Anal Fistula Non-surgical Treatment Market - Supply Chain Analysis 4.3.1 List of Key Suppliers 4.3.2 List of Key Distributors 4.3.3 List of Key Consumers 4.4 Key Forces Shaping the Anal Fistula Non-surgical Treatment Market 4.4.1 Bargaining Power of Suppliers 4.4.2 Bargaining Power of Buyers 4.4.3 Threat of Substitution 4.4.4 Threat of New Entrants 4.4.5 Competitive Rivalry 4.5 Global Anal Fistula Non-surgical Treatment Market Size & Forecast, 2018-2028 4.5.1 Anal Fistula Non-surgical Treatment Market Size and Y-o-Y Growth 4.5.2 Anal Fistula Non-surgical Treatment Market Absolute $ Opportunity
Chapter 5 Global Anal Fistula Non-surgical Treatment Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Anal Fistula Non-surgical Treatment Market Size Forecast by Type
5.2.1 Drugs
5.2.2 Fibrin Glue
5.2.3 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Anal Fistula Non-surgical Treatment Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Anal Fistula Non-surgical Treatment Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Clinics
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Anal Fistula Non-surgical Treatment Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Anal Fistula Non-surgical Treatment Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Anal Fistula Non-surgical Treatment Analysis and Forecast
9.1 Introduction
9.2 North America Anal Fistula Non-surgical Treatment Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Anal Fistula Non-surgical Treatment Market Size Forecast by Type
9.6.1 Drugs
9.6.2 Fibrin Glue
9.6.3 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Anal Fistula Non-surgical Treatment Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Clinics
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Anal Fistula Non-surgical Treatment Analysis and Forecast
10.1 Introduction
10.2 Europe Anal Fistula Non-surgical Treatment Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Anal Fistula Non-surgical Treatment Market Size Forecast by Type
10.6.1 Drugs
10.6.2 Fibrin Glue
10.6.3 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Anal Fistula Non-surgical Treatment Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Clinics
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Anal Fistula Non-surgical Treatment Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Anal Fistula Non-surgical Treatment Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Anal Fistula Non-surgical Treatment Market Size Forecast by Type
11.6.1 Drugs
11.6.2 Fibrin Glue
11.6.3 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Anal Fistula Non-surgical Treatment Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Clinics
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Anal Fistula Non-surgical Treatment Analysis and Forecast
12.1 Introduction
12.2 Latin America Anal Fistula Non-surgical Treatment Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Anal Fistula Non-surgical Treatment Market Size Forecast by Type
12.6.1 Drugs
12.6.2 Fibrin Glue
12.6.3 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Anal Fistula Non-surgical Treatment Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Clinics
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Anal Fistula Non-surgical Treatment Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Anal Fistula Non-surgical Treatment Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Anal Fistula Non-surgical Treatment Market Size Forecast by Type
13.6.1 Drugs
13.6.2 Fibrin Glue
13.6.3 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Anal Fistula Non-surgical Treatment Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Clinics
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Anal Fistula Non-surgical Treatment Market: Competitive Dashboard
14.2 Global Anal Fistula Non-surgical Treatment Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Becton, Dickinson and Company
14.3.2 biolitec AG
14.3.3 Cook Medical
14.3.4 Gem srl
14.3.5 KARL STORZ
14.3.6 Medtronic
14.3.7 TiGenix